Cargando…

Infliximab in young paediatric IBD patients: it is all about the dosing

Infliximab (IFX) is administered intravenously using weight-based dosing (5 mg/kg) in inflammatory bowel disease (IBD) patients. Our hypothesis is that especially young children need a more intensive treatment regimen than the current weight-based dose administration. We aimed to assess IFX pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jongsma, Maria M. E., Winter, Dwight A., Huynh, Hien Q., Norsa, Lorenzo, Hussey, Seamus, Kolho, Kaija-Leena, Bronsky, Jiri, Assa, Amit, Cohen, Shlomi, Lev-Tzion, Raffi, Van Biervliet, Stephanie, Rizopoulos, Dimitris, de Meij, Tim G. J., Shouval, Dror S., Wine, Eytan, Wolters, Victorien M., Martinez-Vinson, Christine, de Ridder, Lissy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666662/ https://www.ncbi.nlm.nih.gov/pubmed/32813123 http://dx.doi.org/10.1007/s00431-020-03750-0

Ejemplares similares

Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and Children
por: Atia, Ohad, et al.
Publicado: (2020)

Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn’s disease
por: Jongsma, Maria M. E., et al.
Publicado: (2022)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
por: Elmaghrawy, Khalid, et al.
Publicado: (2021)

Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD
por: Armstrong, Heather, et al.
Publicado: (2021)

Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020)

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial
por: Jongsma, Maria M E, et al.
Publicado: (2022)

The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World
por: Church, Peter C., et al.
Publicado: (2018)

Circulating α4β7(+) Memory T Cells in Pediatric IBD Patients Express a Polyclonal T Cell Receptor Repertoire
por: Gamliel, Adir, et al.
Publicado: (2020)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Infantile-onset inflammatory bowel disease has variable long-term outcomes
por: Krauthammer, Alex, et al.
Publicado: (2023)

Regulation of CEACAM Family Members by IBD-Associated Triggers in Intestinal Epithelial Cells, Their Correlation to Inflammation and Relevance to IBD Pathogenesis
por: Saiz-Gonzalo, Gonzalo, et al.
Publicado: (2021)

The Oral Microbiome in Treatment-Naïve Paediatric IBD Patients Exhibits Dysbiosis Related to Disease Severity that Resolves Following Therapy
por: Elmaghrawy, Khalid, et al.
Publicado: (2022)

RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features
por: Sultan, Mutaz, et al.
Publicado: (2022)

Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy
por: Sidoroff, Marianne, et al.
Publicado: (2014)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

Trends in Early Outpatient Drug Therapy in Pediatric Inflammatory Bowel Disease in Finland: A Nationwide Register-Based Study in 1999–2009
por: Virta, Lauri J., et al.
Publicado: (2012)

Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD
por: Werner, Lael, et al.
Publicado: (2020)

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
por: Aalto, Kristiina, et al.
Publicado: (2017)

Clustering of pediatric onset inflammatory bowel disease in Finland: a nationwide register-based study
por: Nikkilä, Atte, et al.
Publicado: (2022)

Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
por: Räisänen, Laura, et al.
Publicado: (2023)

A98 ASSOCIATIONS BETWEEN DISTANCE TO CLINIC AND PATIENT CHARACTERISTICS FOR YOUNG ADULTS WITH IBD AT THE TIME OF PEDIATRIC TO ADULT TRANSFER OF CARE
por: Bihari, A, et al.
Publicado: (2023)

Quality of life and colorectal function in Crohn’s disease patients that underwent ileocecal resection during childhood
por: Diederen, Kay, et al.
Publicado: (2019)

Sleep and Emotional and Behavioral Symptoms in Adolescents with Inflammatory Bowel Disease
por: Pirinen, Teija, et al.
Publicado: (2014)

Lactose inhibits regulatory T-cell-mediated suppression of effector T-cell interferon-γ and IL-17 production
por: Paasela, Monika, et al.
Publicado: (2014)

Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases
por: Räisänen, Laura, et al.
Publicado: (2021)

Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series
por: Bayoumy, Ahmed B., et al.
Publicado: (2022)

Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases
por: Zaidi, Deenaz, et al.
Publicado: (2018)

Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis
por: Nousiainen, Pauliina, et al.
Publicado: (2014)

Organophosphate acetylcholine esterase inhibitor poisoning from a home-made shampoo
por: Sadaka, Yair, et al.
Publicado: (2011)

Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group
por: Arrigo, Serena, et al.
Publicado: (2021)

Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD
por: Berkovitch, Gil, et al.
Publicado: (2021)

Sex- and weight-specific changes in the frequency of sweet treat consumption during early adolescence: a longitudinal study
por: Lommi, Sohvi, et al.
Publicado: (2021)

Central obesity in school‐aged children increases the likelihood of developing paediatric autoimmune diseases
por: Räisänen, Laura, et al.
Publicado: (2021)

Quality of life in patients with IBD during the COVID-19 pandemic in the Netherlands
por: de Bock, Ellen, et al.
Publicado: (2021)

A47 MICROBIAL FUNCTIONS AS BIOMARKERS OF PRO-INFLAMMATORY RESPONSE TO SELECT DIETARY FIBERS IN IBD
por: Armstrong, H, et al.
Publicado: (2022)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
por: Aardoom, Martine A., et al.
Publicado: (2019)

The Multifaceted Roles of Diet, Microbes, and Metabolites in Cancer
por: Armstrong, Heather, et al.
Publicado: (2021)

Pre-Diagnostic Saliva Microbiota of School-Aged Children Who Developed Type 1 Diabetes or Inflammatory Bowel Diseases
por: Räisänen, Laura, et al.
Publicado: (2023)

COVID-19 in IBD: The experience of a single tertiary IBD center
por: Rizzello, Fernando, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hug4adr6bgo8bj3c037k9an9ju